Novo Nordisk eyeing Pakistan potential

Pharma giant expects annual growth rates in Pakistan to be about 30 percent

Danish pharmaceutical giant Novo Nordisk has made inroads into the market in Pakistan and expects a rosy future thanks to a growth rate of around 30 percent per year.

Novo Nordisk has almost tripled its employee numbers in Pakistan in a few short years from 53 in 2010 to 153 now, and Lars Rebien Sørensen, the head of Novo Nordisk, sees great potential.

Novo Nordisk has had a subsidiary operating in Pakistan since 2005, but had already launched insulin products in the Pakistani market back in 1989.